Regression of hepatocellular carcinoma with right atrial extension after sorafenib and transarterial chemoembolization

Clin Gastroenterol Hepatol. 2012 Oct;10(10):e83-4. doi: 10.1016/j.cgh.2012.06.031. Epub 2012 Jul 17.

Authors

Madhu Subramanian¹, Amit G Singal, Adam C Yopp

Affiliation

¹ Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

PMID: 22813441
DOI: 10.1016/j.cgh.2012.06.031

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / administration & dosage*
Benzenesulfonates / administration & dosage*
Carcinoma, Hepatocellular / drug therapy*
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / surgery*
Chemoembolization, Therapeutic / methods*
Humans
Liver Neoplasms / drug therapy*
Liver Neoplasms / pathology
Liver Neoplasms / surgery*
Magnetic Resonance Imaging
Male
Middle Aged
Niacinamide / analogs & derivatives
Phenylurea Compounds
Pyridines / administration & dosage*
Radiography, Abdominal
Sorafenib
Tomography, X-Ray Computed
Treatment Outcome

Substances

Antineoplastic Agents
Benzenesulfonates
Phenylurea Compounds
Pyridines
Niacinamide
Sorafenib